摘要
中华医学会神经病学分会及其脑血管病学组和神经血管介入协作组组织相关专家在2015年《中国急性缺血性脑卒中早期血管内介入诊疗指南》的基础上，结合近3年来相关的循证医学证据和我国的实际情况，制订了《中国急性缺血性脑卒中早期血管内介入诊疗指南2018}。本次修订更新了适应证和禁忌证，也更新了治疗时间窗和多模式血管内技术，明确了血压管理和抗栓药物使用的基本原则，希望能为我国卒中血管内治疗提供质量控制规范，促进建立质量监测体系和改进医疗质量。
Chinese guidelines for the endovascular treatment of acute ischemic stroke 2018 are based on the current available evidence and the realities of clinical practice in China. These guidelines supersede the 2015 guidelines. The writing members of the guidelines were appointed by the Chinese Stroke Society and Neurovascular Intervention Group of Chinese Society of Neurology. This revision has updated the indications and contraindications, also updated the time window of treatment and the multimode intravascnlar technology, and clarified the basic principles of the use of blood pressure management and antithrombotic drugs. It is hoped that it can provide quality control norms for the treatment of stroke in China, promote the establishment of quality monitoring system and improve the quality of medical treatment.
作者
刘新峰
叶瑞东
Liu Xinfeng;Ye Ruidong(Department of Neurology,Jinling Hospital,Nanjing 210002,China)
出处
《中华神经科杂志》
CAS
CSCD
北大核心
2018年第9期660-663,共4页
Chinese Journal of Neurology
关键词
脑缺血
卒中
机械溶栓
血栓溶解疗法
Brain ischemia
Stroke
Mechanical thrombolysis
Thrombolytic therapy
